What should you know about photodynamic therapy for lung cancer?

A photosensitising medicine is given and remains in certain cells longer than in surrounding tissue. During bronchoscopy, a clinician directs a specific light onto the tumour or narrowed airway; activation creates a local reaction that can destroy susceptible tumour tissue. This approach is selected for particular airway locations and clinical situations, and it is not suitable for every lung cancer or every stage. The oncology and respiratory teams decide based on scans, bronchoscopy findings, breathing status, and other treatments.

Ask how to prepare for sedation or anaesthesia, which medicines to pause, and when eating and drinking must stop. Arrange transport and follow the breathing and activity instructions after bronchoscopy. Protect your skin and eyes from direct sunlight and strong indoor light for the time specified by the treating team; the medicine can make exposed tissues unusually light-sensitive. Cough, throat irritation, fatigue, or small amounts of blood-tinged mucus may occur after bronchoscopy, but your team should explain what is expected for you.

Contact the treatment team promptly for increasing breathlessness, persistent or heavy bleeding, fever, chest pain, worsening cough, or difficulty swallowing. Seek emergency care for severe breathing difficulty, blue lips, confusion, or collapse. Keep every planned follow-up because airway swelling, retained tissue, or tumour persistence may need assessment and additional care.

Ask why PDT is appropriate for your tumour, what bronchoscopy and sedation involve, how light exposure will be managed at home, which symptoms require emergency help, and how response will be checked.